MARK HEBERT: Open Payments
NPI 1831740331 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $90 · 2025 $571
Food & beverage: $422Education: $149
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $224 |
| GENZYME CORPORATION | 1 | $148 |
| Astellas Pharma US Inc | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $49 |
| Janssen Scientific Affairs, LLC | 1 | $30 |
Products named: RYBREVANT, Padcev, ERLEADA, TECVAYLI.
Industry payments across MA — which companies pay providers there.
